- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New MRI technique tracks infant brain development
Diffusion-tensor and fiber tract reconstruction MR imaging can detect white matter abnormalities that affect children's cognitive skills.
Diffusion-tensor and fiber tract reconstruction MR imaging can detect white matter abnormalities that affect children's cognitive skills. University of Texas researchers say the new tool could help monitor brain development in infants.
Behroze Vachha, Ph.D., and colleagues assessed 13 patients ages six months to 16 years with myelomeningocele and Chiari II malformation who underwent DTI and fiber tract reconstruction. The researchers looked for limbic tract anomalies and their correlation with learning and memory deficiencies in these patients. Using this technique, the investigators confirmed fiber abnormalities in the limbic system of 11 patients with these conditions. They also found a significant association between fornix or cingulum abnormalities and memory and learning problems in these patients.
The researchers published their findings in the July issue of Radiology.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
